Indo-National Limited

Indo-National Announces Book Closure for AGM and Dividend Payment

Indo-National Limited has set September 21, 2026, as the record date for its 53rd AGM and dividend payment. The book closure will be from September 22 to September 28, 2026.

Indo-National to Invest ₹3.91 Crore in Axial Aero, Boosting Stake to 7.97%

Indo-National Limited will invest ₹3.91 crore in Axial Aero Private Limited by subscribing to 35,249 Class C CCPS. This investment will increase its stake to 7.97% on a fully diluted basis. The Board approved the agreements on September 17, 2026.

Indo-National Acquires Additional 0.41% Stake in Medcuore Medical for ₹25 Lakh

Indo-National Limited invested ₹25.02 lakh for an additional 0.41% stake in Medcuore Medical Solutions Private Ltd. This raises its total holding to 62.28%. MMSPL is in the air monitoring and purification business and had a turnover of ₹1.46 crore in FY26. The acquisition aims for business growth and profit generation.

Indo National Ltd to hold 53rd AGM on Sep 28 via VC/OAVM

Indo National Limited will hold its 53rd AGM on September 28, 2026, via VC/OAVM. The record date for voting is September 21, 2026. Remote e-voting is open from September 25 to September 27, 2026.

Indo National Ltd. to Hold 53rd AGM on Sep 28, 2026, via VC/OAVM

Indo National Limited will hold its 53rd AGM on September 28, 2026, via VC/OAVM. The Annual Report for FY 2025-26 is available via a weblink for shareholders with unregistered emails. Shareholders are encouraged to update KYC details.

Indo-National Ltd. announces 53rd AGM on Sept 28, 2026, to consider dividend and financial statements.

Indo-National Limited will hold its 53rd AGM on September 28, 2026, to adopt financial statements and declare a dividend of ₹3.75 per share for FY 2025-26. The agenda includes director re-appointment and approval of remuneration for cost auditors and non-executive independent directors.

Indo National Ltd. announces 53rd AGM on Sep 28, 2026, to declare ₹3.75 dividend

Indo National Limited will hold its 53rd AGM on September 28, 2026, via VC/OAVM. The company plans to declare a dividend of ₹3.75 per equity share for FY 2025-26. The AGM will also approve financial statements and director remuneration. E-voting will be available from September 25-27, 2026.

Indo-National Acquires Additional 0.78% Stake in Medcuore Medical for ₹50 Lakhs

Indo-National Limited invested ₹50.04 Lakhs for an additional 0.78% stake in Medcuore Medical Solutions Private Ltd. This brings Indo-National's total shareholding in MMSPL to 61.87%. The acquisition aims to facilitate business growth and is expected to be completed by FY 2027-28.

Indo-National Limited: Chief Sales Officer Binu Sekhar Resigns

Mr. Binu Sekhar has resigned as Chief Sales Officer (CSO) of Indo-National Limited, effective September 1, 2026. The resignation is attributed to personal health reasons, requiring him to take a break for recovery.

Indo-National Ltd. Publishes Q1 FY27 Unaudited Financial Results

Indo-National Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were published in "Business Line" and "Makkal Kural" on August 15, 2026, and are also available on the company's website.

Indo-National Ltd Q1FY27 Results: Net Loss Widens to ₹22.90 Cr, Declares 53rd AGM on Sep 28

Indo-National Limited reported a consolidated net loss of ₹20.10 crore for Q1FY27, widening from ₹20.90 crore year-on-year. Standalone net loss was ₹22.90 crore. The company announced its 53rd AGM on September 28, 2026, with book closure from September 22-28 for dividend and AGM purposes. E-voting is available from September 25-27.

Indo National Limited Board Meeting Outcome: Q1FY27 Unaudited Results Approved, 53rd AGM on Sep 28

Indo National Limited's Board approved Q1FY27 unaudited results showing a loss. The 53rd AGM is on September 28, 2026, with book closure from Sept 22-28. E-voting is from Sept 25-27. Standalone EPS was ₹0.305, consolidated ₹0.285.

Indo National Ltd Q1FY27 Results: Net Loss Widens to ₹228.97 Lakhs, Declares 53rd AGM on Sep 28

Indo National Ltd reported a net loss of ₹228.97 Lakhs for Q1FY27, compared to a loss of ₹106.80 Lakhs in Q1FY26. Total income was ₹11674.76 Lakhs. The 53rd AGM is scheduled for September 28, 2026, with book closure from September 22-28.

Indo-National Acquires 31.82% Stake in Aidin Technologies for ₹350 Crore

Indo-National Limited acquired a 31.82% stake in Aidin Technologies Private Limited for ₹34.99 crore. The first tranche was completed on July 29, 2026, with the second expected by July 28, 2027. Aidin Technologies operates in defence, space, and aerospace electronics.

Indo-National Acquires Additional 1.18% in Medcuore Medical Solutions for ₹74.9 Lakhs

Indo-National Limited invested ₹74.9 Lakhs for an additional 1.18% stake in Medcuore Medical Solutions Private Ltd (MMSPL). This increases Indo-National's total shareholding in MMSPL to 60.34%. MMSPL operates in Air Monitoring Systems and Air Purifiers.

Indo-National Ltd: Special Window for Re-lodgement of Transfer Requests of Physical Shares Extended

Indo-National Limited announced an extension for its special window to re-lodge transfer requests for physical shares. The window, now valid until February 04, 2027, allows investors to re-submit rejected or unprocessed transfer deeds lodged before April 01, 2019.

Indo-National Acquires Additional 1.68% Stake in Medcuore Medical Solutions for ₹99.88 Lakh

Indo-National Limited invested ₹99.88 lakh for an additional 1.68% stake in Medcuore Medical Solutions Private Ltd, raising its total holding to 59.16%. MMSPL is in the Air Monitoring System and Air Purifier business. The acquisition aims for business growth and is expected to be completed by FY 2027-28.

Indo-National Ltd. Publishes Audited Financial Results for Q4FY26

Indo-National Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company reported a standalone loss after tax of ₹808.03 crore for Q4FY26 and ₹1039.71 crore for FY26. Consolidated loss after tax was ₹2099.91 crore for Q4FY26 and ₹2626.39 crore for FY26.

Indo National Board Recommends ₹3.75 Dividend; Approves Q4 FY26 Results

Indo National Limited approved Q4 FY26 results with a recommended dividend of ₹3.75 per share. Standalone loss after tax was ₹808.03 Lakhs for the quarter and ₹1,039.71 Lakhs for the year. Consolidated loss after tax was ₹2,099.91 Lakhs for the quarter and ₹2,669.20 Lakhs for the year.

Indo-National Ltd Board Approves FY26 Audited Results, Recommends Dividend

Indo-National Limited approved audited standalone and consolidated financial results for the year ended March 31, 2026. The Board recommended a final dividend of ₹3.75 per share. The company also invested ₹693.83 Lakhs in Medcuore Medical Solutions, making it a subsidiary.

Indo-National Acquires Additional 2.69% Stake in Medcuore Medical Solutions for ₹80 Lakh

Indo-National Limited invested ₹80 lakh for an additional 2.69% stake in Medcuore Medical Solutions Private Ltd (MMSPL). The company's total shareholding in MMSPL now reaches 57.48%. The acquisition aims to facilitate business growth and revenue generation. Completion is expected by FY 2027-28.

Indo-National Acquires 51% Stake in Defence Tech Firm Aidin Technologies

Indo-National Limited will acquire a 51% stake in Aidin Technologies Private Limited for a total cash consideration of ₹780.48 crore. The acquisition, to be completed in two tranches by June 2026 and within 12 months thereafter, aims to expand into the Defence & Aerospace sector.

Indo-National Ltd Clarifies Audit Opinion and Results Submission

Indo-National Limited clarified its financial results submission, confirming an unmodified audit opinion for FY24. The company reported a standalone net profit of ₹670.04 Lakhs for FY24 and a consolidated net profit of ₹1463.84 Lakhs. A final dividend of ₹5 per share was recommended.

Indo-National Limited Files SEBI Regulation 74(5) Certificate for FY 2025-26

Indo-National Limited submitted a certificate under SEBI Regulation 74(5) for the year ended March 31, 2026. The RTA confirmed processing of dematerialized securities and updates to the Register of Members.

Indo-National Limited Closes Trading Window from April 1st for Financial Results

Indo-National Limited is closing its trading window from April 1st, 2026, until 48 hours after the announcement of audited financial results for the quarter and year ending March 31st, 2026. This affects designated persons and their immediate relatives.

Indo-National Revises Q2 FY26 Results Due to ₹64.5 Cr Investment Omission

Indo-National Limited revised its Q2 FY26 consolidated financial results due to an omission of ₹64.50 Crores in investments. The error impacted Non-Current Financial Assets, Total Assets, Total Equity, and Segment reporting. The company has corrected these figures, with Total Assets now at ₹50,454.02 Lakhs as of September 30, 2025.

Indo-National Approves Additional ₹70 Lakh Loan to Aidin Technologies

Indo-National Limited approved an additional loan of up to ₹70 Lakhs to Aidin Technologies Private Limited for working capital. The total loan now stands at ₹10.70 Crore. The agreement includes personal guarantees and a pledge of shares by the borrower's promoter. Executed on March 17, 2026.

Indo-National Appoints Arun Sriram as New Chief Marketing Officer

Indo-National Limited appointed Arun Sriram as Chief Marketing Officer, effective March 16, 2026. Sriram has over 16 years of experience in FMCG, startups, and digital growth strategy, having previously worked at iD Fresh Food and ITC Limited.

Indo National Limited receives final NCLT order for Helios Strategic Systems amalgamation

Indo National Limited has received the final order from NCLT sanctioning the amalgamation of Helios Strategic Systems Limited. The scheme becomes effective upon filing with the Registrar of Companies. This consolidation aims to streamline operations and improve efficiency.

Indo National Limited's Amalgamation Scheme Sanctioned by NCLT Chennai

The National Company Law Tribunal (NCLT), Chennai Bench, has sanctioned the Scheme of Amalgamation between Helios Strategic Systems Limited and Indo National Limited. The order was pronounced on March 10, 2026. The scheme becomes effective upon filing with the Registrar of Companies.

Indo-National Limited: Chief Marketing Officer Shardul Bist Resigns Effective March 31, 2026

Mr. Shardul Bist has resigned from his position as Chief Marketing Officer (CMO) of Indo-National Limited. His resignation is effective March 31, 2026, citing personal reasons. He has committed to a smooth transition.

Indo-National Limited Publishes Q3 FY26 Financial Results

Indo-National Limited announced its unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The results were published in "Business Line" and "Makkal Kural" on February 5, 2026, and are available on the company's website.

Indo-National Q3 FY26: Standalone Net Loss ₹661.95 Lakhs, Revenue ₹10,611.30 Lakhs

Indo-National Limited reported Q3 FY26 unaudited standalone revenue of ₹10,611.30 Lakhs and a net loss of ₹661.95 Lakhs. Consolidated revenue was ₹10,630.91 Lakhs with a net loss of ₹1215.03 Lakhs. The company invested ₹568.66 Lakhs in Medcuore Medical Solutions, making it a subsidiary, and ₹850 Lakhs in Axial Aero.

Indo-National Acquires Majority Stake in Medcuore Medical Solutions for ₹6.94 Crore

Indo-National Limited acquired a 54.79% stake in Medcuore Medical Solutions Private Ltd (MMSPL) for ₹6.94 crore, making MMSPL its subsidiary. The acquisition aims to facilitate business growth. The deal is expected to be completed by FY 2027-28.

Indo-National Limited Clarifies XBRL Filing Discrepancy for H1 FY26 Results

Indo-National Limited clarifies a discrepancy in its XBRL filing for the half-year ended September 30, 2025. Quarterly figures were mistakenly submitted instead of half-yearly ones. The revised XBRL filing was submitted on January 12, 2026.

Indo-National Appoints S R Aravind Kumar as New CFO

Indo-National Limited appointed S R Aravind Kumar as Chief Financial Officer and Key Managerial Personnel, effective January 14, 2026. Mr. Kumar, a Chartered Accountant with over 20 years of experience, joined the company as Financial Controller in August 2025.

Indo-National Appoints S R Aravind Kumar as Chief Financial Officer

Indo National Limited appointed S R Aravind Kumar as Chief Financial Officer and Key Managerial Personnel. The appointment is effective January 14, 2026. Mr. Kumar is a Chartered Accountant with over 20 years of experience in finance and accounting.

Indo-National Limited: NCLT Reserves Order on Helios Strategic Systems Amalgamation

The NCLT Chennai Bench has reserved its order on the amalgamation scheme between Indo National Limited and Helios Strategic Systems Limited after a final hearing on January 13, 2026. All statutory authorities, including the Official Liquidator, Regional Director, and Income Tax Department, have raised no objections.

Indo-National Limited: SEBI Compliance Certificate for Q3 FY26 Issued

Indo-National Limited received a SEBI compliance certificate for the quarter ended December 31, 2025. The RTA confirmed processing of dematerialized securities and updates to the Register of Members.

Indo-National Ltd: CFO C R Sivaramakrishnan retires on Dec 31, 2025

Indo-National Limited announces the retirement of its Chief Financial Officer, Mr. C R Sivaramakrishnan. His retirement is effective from the close of business hours on December 31, 2025. The company acknowledges his valuable contributions.

Indo-National Limited Closes Trading Window from Jan 1, 2026 for Q3 Results

Indo-National Limited will close its trading window from January 1, 2026. The window will remain closed until 48 hours after the declaration of the unaudited third quarter results for the period ending December 31, 2025. Designated persons are restricted from trading securities during this period.

NCLT Chennai Bench directs hearing on Amalgamation Scheme for January 13, 2026

NCLT Chennai Bench directs hearing on Amalgamation Scheme for January 13, 2026 after the Official Liquidator recorded no objections to the proposed amalgamation of Helios Strategic Systems Limited and Indo National Limited.

Update on Hearing conducted by the Hon’ble NCLT, Chennai Bench

Indo National Limited announced that the NCLT heard the matter regarding the Scheme of Amalgamation and listed the petition for further hearing on December 10, 2025.

Indo-National Limited Announces Unaudited Results Publication

Indo-National Limited publicized unaudited financial results for the quarter and half-year concluding on September 30, 2025, via newspaper advertisements and its website.

Indo-National Reports Q2 & H1 FY25 Results; Shareholder Approval for Amalgamation

Indo-National reported Q2 & H1 FY25 results. Standalone profits increased, while consolidated profits were impacted by a high base. Shareholder approval received for Helios amalgamation and new investments were made.

Indo-National Ltd Appoints Mr. Shardul Bist as Chief Marketing Officer

Indo-National Limited appointed Mr. Shardul Bist as Chief Marketing Officer, effective October 27, 2025.

Indo-National Limited approves loan of ₹10 Crore to Aidin Technologies

Indo-National Limited approved a ₹10 Crore loan to Aidin Technologies on October 7, 2025, secured by guarantees and share pledges, for working capital needs.

Indo-National Limited's 52nd AGM Approves Financials, Dividend, and Director Appointments

NCLT grants authorities two weeks for reports on Indo-National amalgamation scheme; next hearing Oct 29

Indo-National resolves XBRL filing issues for FY25 financial results with NSE